13G INITIAL ANNUAL FILING - CLDX

Company

Celldex Therapeutics, Inc.

Filed

February 11, 2013

Accession Number

0000053417-13-000020

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →